348 related articles for article (PubMed ID: 12894524)
1. The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
Lincoln DT; Ali Emadi EM; Tonissen KF; Clarke FM
Anticancer Res; 2003; 23(3B):2425-33. PubMed ID: 12894524
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin and thioredoxin reductase expression in thyroid cancer depends on tumour aggressiveness.
Lincoln DT; Al-Yatama F; Mohammed FM; Al-Banaw AG; Al-Bader M; Burge M; Sinowatz F; Singal PK
Anticancer Res; 2010 Mar; 30(3):767-75. PubMed ID: 20392995
[TBL] [Abstract][Full Text] [Related]
3. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
[TBL] [Abstract][Full Text] [Related]
4. Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis.
Maurice MM; Nakamura H; Gringhuis S; Okamoto T; Yoshida S; Kullmann F; Lechner S; van der Voort EA; Leow A; Versendaal J; Muller-Ladner U; Yodoi J; Tak PP; Breedveld FC; Verweij CL
Arthritis Rheum; 1999 Nov; 42(11):2430-9. PubMed ID: 10555039
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
Gallegos A; Berggren M; Gasdaska JR; Powis G
Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation.
Karimpour S; Lou J; Lin LL; Rene LM; Lagunas L; Ma X; Karra S; Bradbury CM; Markovina S; Goswami PC; Spitz DR; Hirota K; Kalvakolanu DV; Yodoi J; Gius D
Oncogene; 2002 Sep; 21(41):6317-27. PubMed ID: 12214272
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.
Berggren M; Gallegos A; Gasdaska JR; Gasdaska PY; Warneke J; Powis G
Anticancer Res; 1996; 16(6B):3459-66. PubMed ID: 9042207
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin reductase as a novel molecular target for cancer therapy.
Nguyen P; Awwad RT; Smart DD; Spitz DR; Gius D
Cancer Lett; 2006 May; 236(2):164-74. PubMed ID: 15955621
[TBL] [Abstract][Full Text] [Related]
9. Induction of thioltransferase and thioredoxin/thioredoxin reductase systems in cultured porcine lenses under oxidative stress.
Moon S; Fernando MR; Lou MF
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3783-9. PubMed ID: 16186363
[TBL] [Abstract][Full Text] [Related]
10. The thioredoxin system in cancer.
Arnér ES; Holmgren A
Semin Cancer Biol; 2006 Dec; 16(6):420-6. PubMed ID: 17092741
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
12. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
Hu J; Ma X; Lindner DJ; Karra S; Hofmann ER; Reddy SP; Kalvakolanu DV
Oncogene; 2001 Jul; 20(31):4235-48. PubMed ID: 11464290
[TBL] [Abstract][Full Text] [Related]
13. The relationship of the redox potentials of thioredoxin and thioredoxin reductase from Drosophila melanogaster to the enzymatic mechanism: reduced thioredoxin is the reductant of glutathione in Drosophila.
Cheng Z; Arscott LD; Ballou DP; Williams CH
Biochemistry; 2007 Jul; 46(26):7875-85. PubMed ID: 17550271
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma.
Turunen N; Karihtala P; Mantyniemi A; Sormunen R; Holmgren A; Kinnula VL; Soini Y
APMIS; 2004 Feb; 112(2):123-32. PubMed ID: 15056229
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin induced antioxidant gene expressions in human lens epithelial cells.
Yegorova S; Yegorov O; Lou MF
Exp Eye Res; 2006 Oct; 83(4):783-92. PubMed ID: 16712839
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
Holmgren A; Lu J
Biochem Biophys Res Commun; 2010 May; 396(1):120-4. PubMed ID: 20494123
[TBL] [Abstract][Full Text] [Related]
17. Electro-acupuncture potentiates the disulphide-reducing activities of thioredoxin system by increasing thioredoxin expression in ischemia-reperfused rat brains.
Siu FK; Lo SC; Leung MC
Life Sci; 2005 Jun; 77(4):386-99. PubMed ID: 15894008
[TBL] [Abstract][Full Text] [Related]
18. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin-linked peroxidase from human red blood cell: evidence for the existence of thioredoxin and thioredoxin reductase in human red blood cell.
Cha MK; Kim IH
Biochem Biophys Res Commun; 1995 Dec; 217(3):900-7. PubMed ID: 8554614
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
Söderberg A; Sahaf B; Rosén A
Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
